Statins for multiple sclerosis

Lancet. 2004;364(9432):412; author reply 412-3. doi: 10.1016/S0140-6736(04)16752-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Brain / pathology
  • Disease Progression
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Recurrence

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors